Neurofilament Light Chain: A Potential ALS Biomarker?
Dec 29, 2020•22 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Biomarkers are an important part of medical research and drug development. A biomarker is a broad term that describes some sort of measurable property of the body, especially one that can tell us something about a disease. Common examples are glucose levels for type one diabetes and blood pressure for hypertension.
Today on Endpoints, ALS TDI CEO Dr. Steve Perrin joins us to talk about what a biomarker is, how they’re used in drug research, and a promising possible biomarker for ALS and other neurodegenerative diseases: Neurofilament Light Chain.
Support the show: https://www.als.net/donate/
See omnystudio.com/listener for privacy information.
For the best experience, listen in Metacast app for iOS or Android